Acute Stroke Treatment in Patients Receiving Direct Oral Anticoagulants: Is it Time to Review the Guidelines?
作者信息
Ojha Pawan K, Aundhakar Aditya
机构信息
Director of Neurology, Fortis Hiranandani Hospital, Navi Mumbai, Maharashtra, India.
Consultant Neurologist, Fortis Hiranandani Hospital, Navi Mumbai, Maharashtra, India.
出版信息
Ann Indian Acad Neurol. 2023 May-Jun;26(3):215-216. doi: 10.4103/aian.aian_241_23. Epub 2023 Jun 15.
Abstract
摘要
相似文献
1
Acute Stroke Treatment in Patients Receiving Direct Oral Anticoagulants: Is it Time to Review the Guidelines?接受直接口服抗凝剂治疗的急性中风患者：是时候重新审视指南了吗？
Ann Indian Acad Neurol. 2023 May-Jun;26(3):215-216. doi: 10.4103/aian.aian_241_23. Epub 2023 Jun 15.
2
Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.直接口服抗凝剂上市后和国家指南改变对卒中二级预防的住院推荐和抗凝药物处方的改变。
Cerebrovasc Dis. 2020;49(4):412-418. doi: 10.1159/000509416. Epub 2020 Aug 5.
3
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.已知心房颤动患者卒中前抗凝治疗的使用率及影响因素
Cerebrovasc Dis Extra. 2020;10(2):44-49. doi: 10.1159/000506923. Epub 2020 May 6.
4
Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants.缺血性卒中和短暂性脑缺血发作的抗凝治疗：直接口服抗凝剂时代的结局。
Intern Med J. 2020 Jan;50(1):110-113. doi: 10.1111/imj.14652.
5
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol.直接口服抗凝剂治疗脑静脉血栓形成：系统评价方案。
Syst Rev. 2019 Apr 18;8(1):99. doi: 10.1186/s13643-019-1022-8.
6
Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.直接口服抗凝剂用于血液系统恶性肿瘤患者预防静脉血栓栓塞和中风的安全性及有效性
J Oncol Pharm Pract. 2020 Mar;26(2):351-360. doi: 10.1177/1078155219848810. Epub 2019 May 29.
7
Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA Study.心房颤动患者抗凝治疗模式的真实世界评估：来自多中心ROTA研究的数据。
Turk Kardiyol Dern Ars. 2023 Mar;51(2):88-96. doi: 10.5543/tkda.2022.98455.
8
Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.非维生素K拮抗剂口服抗凝药在心血管疾病管理中的应用：证据与未解决的问题
J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3.
9
Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry - Study Design and Characteristics.多中心前瞻性分析口服抗凝剂治疗的卒中患者：PASTA 登记研究-研究设计和特征。
J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104456. doi: 10.1016/j.jstrokecerebrovasdis.2019.104456. Epub 2019 Oct 29.
10
Management of acute stroke in patients taking novel oral anticoagulants.服用新型口服抗凝剂患者的急性卒中管理
Int J Stroke. 2014 Jul;9(5):627-32. doi: 10.1111/ijs.12295. Epub 2014 Jun 2.
本文引用的文献
1
Safety of Recanalization Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulant Therapy: An Updated Systematic Review and Meta-Analysis.直接口服抗凝治疗的急性缺血性中风患者再通治疗的安全性：最新系统评价与荟萃分析
Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):1036-1046. doi: 10.4103/aian.aian_271_22. Epub 2022 Nov 4.
2
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants.缺血性脑卒中且近期服用直接口服抗凝剂患者的静脉溶栓治疗。
JAMA Neurol. 2023 Mar 1;80(3):233-243. doi: 10.1001/jamaneurol.2022.4782.
3
Adjunctive Intra-arterial Thrombolysis in Endovascular Thrombectomy: A Systematic Review and Meta-analysis.血管内血栓切除术的辅助动脉内溶栓：一项系统评价和荟萃分析。
Neurology. 2021 Jun 14;96(24):1135-1143. doi: 10.1212/WNL.0000000000012112.
4
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.欧洲卒中组织（ESO）急性缺血性卒中静脉溶栓指南。
Eur Stroke J. 2021 Mar;6(1):I-LXII. doi: 10.1177/2396987321989865. Epub 2021 Feb 19.
5
Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.缺血性脑卒中合并心房颤动患者的抗凝治疗前评估。
Ann Neurol. 2021 Jan;89(1):42-53. doi: 10.1002/ana.25917. Epub 2020 Oct 17.
6
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.直接口服抗凝药物的应用：常见临床挑战的实用指南。
J Am Heart Assoc. 2020 Jul 7;9(13):e017559. doi: 10.1161/JAHA.120.017559. Epub 2020 Jun 15.
7
Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages.评估andexanet alfa和四因子凝血酶原复合物浓缩剂（4F-PCC）对利伐沙班和阿哌沙班相关颅内出血的逆转作用。
J Thromb Haemost. 2020 Jul;18(7):1637-1647. doi: 10.1111/jth.14838. Epub 2020 May 12.
8
Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort.达比加群酯逆转剂依达鲁单抗治疗后国家队列的卒中再灌注治疗。
Neurology. 2020 May 12;94(19):e1968-e1972. doi: 10.1212/WNL.0000000000009155. Epub 2020 Feb 20.
9
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.德国因缺血性卒中或颅内出血使用idarucizumab拮抗达比加群的情况——120 例更新系列。
Int J Stroke. 2020 Aug;15(6):609-618. doi: 10.1177/1747493019895654. Epub 2020 Jan 19.
10
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.直接口服抗凝剂治疗患者静脉溶栓的安全性：系统评价和荟萃分析。
Stroke. 2020 Feb;51(2):533-541. doi: 10.1161/STROKEAHA.119.026426. Epub 2019 Dec 30.
Zotero 插件